期刊文献+

过氧化体增殖物激活型受体γ对巨噬细胞脂质蓄积及CD36表达的影响 被引量:9

Effect of Peroxisome Proliferator-Activated Receptor-γ on Cholesterol Accumulation and CD36 Expression in THP-1 Macrophages
下载PDF
导出
摘要 目的观察过氧化体增殖物激活型受体γ激动剂和拮抗剂对THP-1巨噬细胞胆固醇蓄积及CD36表达的影响。方法实验分对照组、氧化型低密度脂蛋白组、Ciglitazone处理组和GW9662处理组,后两组用50 mg/L氧化型低密度脂蛋白分别与过氧化体增殖物激活型受体γ激动剂Ciglitazone(10μmol/L)及拮抗剂GW9662(10μmol/L)共同孵育24 h,高效液相色谱分析法检测细胞总胆固醇蓄积情况,RT-PCR和Western blot分别检测THP-1巨噬细胞CD36 mRNA和蛋白的表达。结果与对照组(76.28±10.36 mg/g)相比,氧化型低密度脂蛋白(121.63±13.32 mg/g)能使细胞总胆固醇含量显著增加,而Ciglitazone能使氧化型低密度脂蛋白处理的细胞总胆固醇含量进一步增加(136.23±14.78 mg/g),GW9662能使氧化型低密度脂蛋白处理的细胞总胆固醇含量减少(98.52±11.45 mg/g)。过氧化体增殖物激活型受体γ拮抗剂GW9662使巨噬细胞CD36 mRNA和蛋白的表达下调及胆固醇蓄积减少,过氧化体增殖物激活型受体γ激动剂Ciglitazone使巨噬细胞CD36 mRNA和蛋白的表达上调及胆固醇蓄积增多。结论过氧化体增殖物激活型受体γ拮抗剂使THP-1巨噬细胞胆固醇蓄积减少及氧化型低密度脂蛋白诱导的CD36表达下调。 Aim To investigate the effects of peroxisome proliferator-activated receptor-γ(PPARγ) on cholesterol accumulation and CD36 expression in THP-1 macrophages. Methods Mononuclear cells were induced to differentiate into THP-1 macrophages by phorbol myristate acetate(160 nmol/L) co-incubation for 24 h.THP-1 macrophages were co-incubated with 50 mg/L oxidize low-density lipoprotein(ox-LDL) and PPARγ agonist Ciglitazone(10 μmol/L;C)and PPARγ antagonist GW9662(10 μmol/L;D)for 24 h,and the cells mixed with(B) and without(A) ox-LDL were as the control groups.Cellular total cholesterol was determined by high performance liquid chromatography analysis.CD36 mRNA and protein levels were determined by reverse transcription-polymerase chain reaction(RT-PCR) and Western blot respectively. Results High performance liquid chromatography analysis demonstrated the amount of cellular total cholesterol were 76.28±10.36(A),121.63±13.32(B),136.23±14.78(C),98.52±11.45(D) mg per gram protein.PPARγ antagonist GW9662 inhibited CD36 mRNA and protein synthesis.Ciglitazone increased CD36 mRNA and protein synthesis.The ratios of CD36/GAPDH were 0.78(A),0.94(B),1.12(C),0.52(D) respectively.Western blot results conform to RT-PCR outcomes. Conclusion Antagonist of PPARγ may decrease cholesterol accumulation and downregulate ox-LDL-induced CD36 expression in THP-1 macrophages.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2012年第2期121-124,共4页 Chinese Journal of Arteriosclerosis
基金 湖南省教育厅重点基金项目(09A078)
关键词 THP-1巨噬细胞 CD36 过氧化体增殖物激活型受体Γ 氧化型低密度脂蛋白 脂质蓄积 THP-1 Mcrophage Class B Scavenger Receptor CD36 Peroxisome Proliferator-Activated Receptor-γ Oxidize Low-Density Lipoprotein Cholesterol Accumulation
  • 相关文献

参考文献10

  • 1Febbraio M,Hajjar DP,Silverstein RL.CD36:a class Bscavenger receptor involved in angioigenesis,atherosclero-sis,inflammation,and lipid metabolism[J].J Clin Invest,2001,108(6):785-791.
  • 2靳文英(综述,陈红(审校).CD36与动脉粥样硬化[J].中国动脉硬化杂志,2010,18(7):582-585. 被引量:13
  • 3孙琳,冯惊涛,易光辉.B类Ⅰ型清道夫受体与胆固醇的双向转运[J].中国动脉硬化杂志,2007,15(1):67-70. 被引量:2
  • 4Collot-Teixeira S,Martin J,McDermott-Roe C,et al.CD36 and macrophages in atherosclerosis[J].Cardio VascRes,2007,75(3):468-477.
  • 5Nicholson AC,Febbraio M,Han J,et al.CD36 in athero-sclerosis:the role of a class B macrophage scavenger recep-tor[J].Ann N Y Acad Sci,2000,902:128-131.
  • 6Majdalawieh A,Ro HS.PPAR gamma1 and LXR alphaface a new regulator of macrophage cholesterol homeostasisand inflammatory responsiveness,AEBP1[J].Nucl Re-cept Signal,2010,8:e004.
  • 7易光辉,唐朝克,莫中成,杨永宗.PPAR在动脉粥样硬化发生与发展中的作用[J].生命的化学,2004,24(3):240-242. 被引量:10
  • 8Kashiwagi H,Tomiyama Y,Kosugi Y,et al.Identificationof the molecular defects in a subject with typeⅠCD36 de-ficiency[J].Blood,1994,83(12):3 545-552.
  • 9Matsumoto K,Hirano K,Nozaki S,et al.Expression ofmacrophage(Mφ)scavenger receptor,CD36,in culturedhuman aortic smooth muscle cells in association with ex-pression of peroxisome proliferator activated receptor-γ,which regulates gain of Mφ-like phenotype in vitro,and itsimplication in atherogenesis[J].Arterioscler Thromb VascBiol,2000,20:1 027-032.
  • 10Nicholson AC.Expression of CD36 in macrophages andatherosclerosis:the role of lipid regulation of PPAR gam-ma signaling[J].Trends Cardiovasc Med,2004,14(1):8-12.

二级参考文献73

  • 1谢湘竹,赵水平.动脉粥样硬化研究的新靶点:B族Ⅰ型清道夫受体[J].中国循环杂志,2005,20(6):479-481. 被引量:4
  • 2谢湘竹,赵水平,贺达仁.关于B族I型清道夫受体研究进展的认识[J].医学与哲学(B),2006,27(2):55-57. 被引量:1
  • 3[1]Martin-Nizard F et al. J Cardiovasc Pharmacol, 2002, 40(6): 822-831
  • 4[2]Duez H et al. J Biol Chem, 2002, 277(50): 48051-48057
  • 5[3]Han KH et al. Trends Cardiovasc Med, 2000, 10(5): 209-216
  • 6[4]Jackson SM et al. Arterioscler Thromb Vasc Biol, 1999, 19(9): 2094-2104
  • 7[5]Pasceri V et al. Circulation, 2000, 101: 235-238
  • 8[6]Collins AR et al. Arterioscler Thromb Vasc Biol, 2001, 21(3): 365-371
  • 9[7]Chawla A et al. Nat Med, 2001, 7(1): 48-52
  • 10[8]Daugherty A et al. J Clin Invest, 2000, 105(11): 1605-1612

共引文献22

同被引文献119

  • 1刘韵蝉,赵兰,梅元英.慢性阻塞性肺疾病患者脂质代谢研究[J].贵阳医学院学报,2001,26(1):34-35. 被引量:8
  • 2齐永秀,高允生,费洪荣,曲晓兰,高艳霞.高效液相色谱法测定鸡蛋蛋黄中胆固醇含量[J].药物生物技术,2005,12(4):258-260. 被引量:15
  • 3赵征,文玲英,金岩.金属蛋白酶解离素家族的研究进展[J].牙体牙髓牙周病学杂志,2006,16(8):470-477. 被引量:2
  • 4Silverstein RL, Li W, Park YM, et al. Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis [ J]. Trans Am Clin Climatol Assoc, 2010, 121: 206-220.
  • 5Neculai D, Sehwake M, Ravichandran hi, et al. Structure of LIMP- 2 provides functional insights with implications for SR-BI and CD36 [J]. Nature, 2013, 504 (7478) : 172-176.
  • 6Afonso Mda S, Castilho G, Lavrador MS, et al. The impact of diet- ary fatty acids on macrophage cholesterol homeostasis [ J ]. J Nutr Biochem, 2014, 25 (2) : 95-103.
  • 7Bao Y, Wang L, Xu Y, et al. Salvianolic acid B inhibits macro- phage uptake of modified low density lipoprotein (mLDL) in a scav- enger receptor CD36-dependent manner[J]. Atherosclerosis, 2012, 223 ( 1 ) : 152-159.
  • 8Chavez-Sanchez L, Garza-Reyes MG: Espinosa-Luna JE, et al. The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to ox-LDL in humans[ J]. Hum Immunol, 2014, 75 (4) : 322-329.
  • 9Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year2010[J]. Diabetes Res Clin Pract, 2010, 87 (1) : 15-19.
  • 10Cioffi G, Rossi A, Targher G, et al. Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitus[ J]. Am J Cardiol, 2014, 113 (8) : 1 409-414.

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部